Login/Sign Up
Online payment accepted
Provide Delivery Location
Whats That
Therapeutic Class
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
SGLTR-M Tablet contains Remogliflozin etabonate and Metformin hydrochloride. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
Do not stop taking SGLTR-M Tablet without consulting your doctor, as it may cause an increase in blood glucose levels. Continue taking SGLTR-M Tablet for as long as your doctor has prescribed it to you. Do not be reluctant to speak with your doctor if you experience any difficulty while taking SGLTR-M Tablet .
Hypoglycaemia/low blood sugar levels could be the side effect of SGLTR-M Tablet . Hypoglycaemia generally occurs when SGLTR-M Tablet is taken along with other antidiabetic medicines, without food or with alcohol. Consume sugary food such as candy or fruit juice if you experience hypoglycaemic symptoms such as dizziness, cold sweats, anxiety, or tremor. Regularly monitor blood glucose levels while taking SGLTR-M Tablet .
If you miss a dose, try to take it as soon as you remember. However, if it is almost time for the scheduled dose, skip the missed dose and take the scheduled dose instead. Avoid taking a double dose as it might cause unpleasant side effects or overdose.
Low-fibre/high-fat diet, sugary diet, obesity, smoking, stress, lack of exercise, age, genetic factors, and certain medical conditions are the common causes of diabetes.
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking SGLTR-M Tablet to prevent unpleasant side effects.
Pregnancy
Caution
Please consult your doctor if you have any concerns regarding this; your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Please consult your doctor if you have any concerns regarding this; your doctor will decide whether SGLTR-M Tablet can be given to breastfeeding mothers or not.
Driving
Caution
It is not known if SGLTR-M Tablet affects your ability to drive. Drive or operate machinery only if you are alert.
Liver
Caution
Dose adjustment may be needed. Please consult your doctor if you have a liver impairment or any concerns regarding this.
Kidney
Caution
Dose adjustment may be needed. Please consult your doctor if you have kidney impairment or any concerns regarding this.
Children
Caution
Limited information is available regarding the usage of SGLTR-M Tablet in children, so please consult a doctor.
About SGLTR-M Tablet
SGLTR-M Tablet belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. It is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.
SGLTR-M Tablet is a combination of two drugs, namely: Remogliflozin etabonate and Metformin hydrochloride. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
You are advised to take SGLTR-M Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as stomach upset, hypoglycaemia, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to consult your doctor if the side effects persist or worsen.
Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking SGLTR-M Tablet as it might cause unpleasant side-effects. Limited information is available regarding the usage of SGLTR-M Tablet in children, so please consult a doctor if you have any concerns. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.
Uses of SGLTR-M Tablet
Medicinal Benefits
SGLTR-M Tablet is a combination of two anti-diabetic drugs, namely: Remogliflozin etabonate and Metformin hydrochloride. SGLTR-M Tablet is used to treat type-2 diabetes mellitus. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
Directions for Use
Side Effects of SGLTR-M Tablet
Drug Warnings
Do not take SGLTR-M Tablet if you are allergic to any of its contents. Inform your doctor if you have heart problems, diabetic ketoacidosis, skin problems, acute pancreatitis, low blood sugar levels, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking SGLTR-M Tablet as it might cause unpleasant side-effects. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects.
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise
Have a query?
Buy best Diabetics products by
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Eris Life Sciences Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Micro Labs Ltd
Mankind Pharma Pvt Ltd
Lloyd Healthcare Pvt Ltd
Alkem Laboratories Ltd
Abbott India Ltd
Glenmark Pharmaceuticals Ltd
Cipla Ltd
Macleods Pharmaceuticals Ltd
Wockhardt Ltd
Dr Reddy's Laboratories Ltd
Primus Remedies Pvt Ltd
USV Pvt Ltd
Aristo Pharmaceuticals Pvt Ltd
Emcure Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Ipca Laboratories Ltd
La Renon Healthcare Pvt Ltd
Ajanta Pharma Ltd
Medley Pharmaceuticals Ltd
East West Pharma India Pvt Ltd
Elbrit Life Sciences Pvt Ltd
Corona Remedies Pvt Ltd
Hbc Life Sciences Pvt Ltd
Sinsan Pharmaceuticals Pvt Ltd
Ranmarc Labs
Mitoch Pharma Pvt Ltd
Zydus Healthcare Ltd
Sanofi India Ltd
Akumentis Healthcare Ltd
Fusion Health Care Pvt Ltd
Unison Pharmaceuticals Pvt Ltd
Jubilant Lifesciences Ltd
Novo Nordisk India Pvt Ltd
Tas Med India Pvt Ltd
Blue Cross Laboratories Pvt Ltd
Msn Laboratories Pvt Ltd
Eswar Therapeutics Pvt Ltd
Indoco Remedies Ltd
Q Check Pharmaceuticals
Alteus Biogenics Pvt Ltd
Anthem Bio Pharma
Franco Indian Pharmaceuticals Pvt Ltd
Systopic Laboratories Pvt Ltd
Panacea Biotec Ltd
Zydus Cadila
Biocon Ltd
Edoc Life Sciences Pvt Ltd
Koye Pharmaceuticals Pvt Ltd
Arkas Pharma Pvt Ltd
Diacardus Pharmacy Pvt Ltd
Elinor Pharmaceuticals (P) Ltd
Remedy Life Sciences Pvt Ltd
Saan Labs
Talent India Pvt Ltd
Jarun Pharmaceuticals Pvt Ltd
Capital Pharma
Shrrishti Health Care Products Pvt Ltd
FDC Ltd
Leeford Healthcare Ltd
Nirvana India Pvt Ltd
Elder Pharmaceuticals Ltd
Eli Lilly and Company (India) Pvt Ltd
Glynis Pharmaceuticals Pvt Ltd
Zuventus Healthcare Ltd
Arrient Healthcare Pvt Ltd
Cadomed Pharmaceuticals India Pvt Ltd
Orris Pharmaceuticals
Akesiss Pharma Pvt Ltd
Bal Pharma Ltd
Biochem Pharmaceutical Industries Ltd
Knoll Healthcare Pvt Ltd
Lippon Pharma Pvt Ltd
Morepen Laboratories Ltd
Neucure Lifesciences Pvt Ltd
Opsis Care Lifesciences Pvt Ltd
Wallace Pharmaceuticals Pvt Ltd
Acmedix Pharma Llp
Converge Biotech Pvt Ltd
Erinyle Pharma
Indiabulls Pharmaceuticals Pvt Ltd
Ozone Pharmaceuticals Ltd
Retra Life Science Pvt Ltd
Alvio Pharmaceuticals Pvt Ltd
Geneaid Pharmaceuticals
Heal (India) Laboratories Pvt Ltd
Olcare Laboratories Pvt Ltd
Vasu Organics Pvt Ltd
Kotak Life Sciences
Lakshya Life Sciences Pvt Ltd
Proqol Health Care Pvt Ltd
Sanz Pharmaceuticals
Daylon healthcare pvt Ltd
Mcronus Lifescience Pvt Ltd
Natco Pharma Ltd
Orsim Pharma
Customers Also Bought
Recommended for a 30-day course: 3 Strips